Qualification Type: | PhD |
---|---|
Location: | Manchester |
Funding for: | UK Students |
Funding amount: | £19,237 for 2024/25 |
Hours: | Full Time |
Placed On: | 9th December 2024 |
---|---|
Closes: | 3rd March 2025 |
How to apply: please click on the 'Apply' button above.
Number of positions: one
This is a Photon Science Institute studentship. It's directly funded at the standard UKRI rate for 3.5 years for UK students only. Tuition fees will be paid and you will receive an annual tax free stipend set at the UKRI rate (£19,237 for 2024/25).
Non-linear flows of antibodies will be explored using next generation photonics techniques during this PhD studentship; a partnership between the Department of Physics and Astronomy at the University of Manchester and FUJIFILM Diosynth Biotechnologies. Monoclonal antibodies (mAbs) are produced at increasingly high concentrations to provide economy of scale during manufacturing and are formulated at increasingly high concentrations to improve patient outcomes e.g. in immunological treatments of cancers to reduce the evolution of resistant tumours.
Flows of mAbs demonstrate a series of challenges:
We have a suite of photonic instrumentation that will be used to explore flow behaviour of concentrated mAbs that involve phenomena i), ii) and iii). We will examine:
Applicants should have, or expect to achieve, at least a 2.1 honours degree or a master’s (or international equivalent) in a relevant science or engineering related discipline.
Please contact the supervisor, Dr Thomas Waigh (t.a.waigh@manchester.ac.uk) before you apply. Please include details of your current level of study, academic background and any relevant experience and include a paragraph about your motivation to study this PhD project.
Type / Role:
Subject Area(s):
Location(s):